Non-specific immunity in patients with primary anogenital warts treated with interferon alpha plus cryotherapy or cryotherapy alone
- PMID: 1350140
Non-specific immunity in patients with primary anogenital warts treated with interferon alpha plus cryotherapy or cryotherapy alone
Abstract
Combination treatment of primary anogenital warts with subcutaneous interferon alpha 2a plus cryotherapy was no more efficacious than cryotherapy alone. Patients with primary AG warts showed no in vitro or in vivo suppression of non-specific immunity. In patients treated with interferon plus cryotherapy non-specific cellular immunity was stimulated, both in vitro and in vivo compared with patients treated with cryotherapy alone.
Similar articles
-
[Treatment of anogenital warts].Bratisl Lek Listy. 1984 Apr;81(4):472-5. Bratisl Lek Listy. 1984. PMID: 6713226 Slovak. No abstract available.
-
Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study.Genitourin Med. 1991 Aug;67(4):297-302. doi: 10.1136/sti.67.4.297. Genitourin Med. 1991. PMID: 1916791 Free PMC article. Clinical Trial.
-
[Adjuvant systemic interferon alpha-2B treatment in treatment refractory anogenital Condylomata acuminata].Urologe A. 1990 Jan;29(1):43-5. Urologe A. 1990. PMID: 2316080 German.
-
[Interferons in the treatment of anogenital condylomas].Acta Urol Belg. 1993 Jan-Jun;61(1-2):323-6. Acta Urol Belg. 1993. PMID: 8517249 Review. French. No abstract available.
-
Interferon: current and future clinical uses in infectious disease practice.Int J STD AIDS. 1992 Jan-Feb;3(1):4-9. doi: 10.1177/095646249200300102. Int J STD AIDS. 1992. PMID: 1543767 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical